AGORA

There is no shortage of problems worth solving.

Capability used to be scarce. AI is making it abundant — so the bottleneck moves to knowing which problems are worth the time. Agora turns that judgment into a market: every unsolved problem gets a price, set by the crowd.

Every market is one unsolved problem.

Its price is what the crowd believes solving that problem is worth. See a problem the market is underrating? Buy in. As others come around and buy too, the price rises — and a live, honest ranking of what’s worth building emerges. You’re not trading a ticker. You’re pricing a problem.

Live problem market
Diagnostic-grade blood testing from a single at-home finger prick.
$0.87
▲ 18.6%
past week · $2.14M market

What grounds the price?

A problem is only worth pricing if that price can settle into something real. On Agora, a share in a problem market is a claim on whoever solves it. When a team forms to take the problem on, they offer equity to the market — and your problem-market shares can convert into shares of that company. That convertibility is the anchor.

From a priced problem to a piece of the company.

01
$1.0M
A problem opens as a market
Priced by the crowd from day one — before any company exists.
02
You buy in
You think it's underpriced
You believe the solution is worth far more, so you buy shares.
03
$2.0M
The market grows
Others agree it was underpriced and buy in. Your shares rise.
04
A company pitches
A team steps forward
Founders offer a chunk of equity to the problem market.
05
You convert
Transfer shares to equity
Holders elect to move problem-market shares into company shares.
06
$500K
Founders accept the round
The seed round closes at an early-stage valuation.
07
X%
You hold equity
You own a piece of the company — from before it existed.
08
Updates ship
The company reports back
Big moments broadcast to the crowd of Agora backers as it grows.
Worked example

A problem’s market is valued at $1M. You believe the solution is worth $5M, so you buy in early. The crowd catches up, a founder steps forward, and your conviction can become equity in the company that solves it. The cheaper you buy shares in a problem, the cheaper your access to equity.

We’re building the real thing.

Agora is navigating the federal exemptions required to operate the platform in the US. In the meantime, show your support by joining the waitlist — and be first in line when it opens.

Real-money markets and equity conversion are gated behind US regulatory approval and are not yet open. The waitlist reserves your place; it is not an offer to sell or a solicitation to buy any security, and implies no launch date or return.
Coming soon

Learn how these markets move. No money required.

Agora’s paper-money app is almost here — real markets, real mechanics, zero risk. Get in early, find the problems you think everyone’s underrating, and discover your strategy before real money is on the line.

App Store
Coming soon
Google Play
Coming soon
AGORA9:41
$77,305.48
+$1,389.19 (+1.82%) today
Buying power$211,051.45
Needs attention
Common infections are killing again as antibiotic resistance outpaces new R&D
MDMeridian Diagnostics · 4d left
Finance
Many businesses can’t scale and end up flaming out
$71,760.40
▲ 7,076%
AGORA9:41
Climate / Energy
Deep sea shipping still burns heavy fossil bunker fuel with no scalable clean alternative
$0.90
▲ 5,763.6% · $4M market
BuySell
AGORA9:41
Full platform waitlistYou’re in line
Recommended for you
Climate / Energy
Deep sea shipping still burns heavy fossil bunker fuel
$4M market▲ 37.7%$0.90/sh
EVEli Vasquez — mira’s point about needing the adoption layer first is what’s been…